Iovance Biotherapeutics, Inc. (IOVA) Profit Margin
Iovance Biotherapeutics, Inc. (IOVA) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | -37345.42% |
| 2024-12-31 | -226.84% |
| 2025-12-31 | -148.39% |
How IOVA compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | -85.44% |
| VNDA | Vanda Pharmaceuticals Inc. | -102.02% |
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| SNDX | Syndax Pharmaceuticals Inc. | -165.60% |
| AQST | Aquestive Therapeutics Inc. | -188.09% |
These are five companies in the same sector as IOVA with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("IOVA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IOVA | $6.40 | +0.95% | 17.27M |
| 3 | ||||
| 4 | ||||
| 5 |